Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection

Howe AYM, Black S, Curry S, Ludmerer SW, Liu R, Barnard RJO, et al. Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2014;59(12):1657 - 1665.

Publication Type:

Journal Article

Source:

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, Volume 59, Issue 12, p.1657 - 1665 (2014)

Keywords:

Drug Resistance, Viral, Genotype, Hepatitis C, hepatitis C genotype 1, Humans, Interferons, MK-5172, Quinoxalines, resistance-associated variants, Ribavirin, treatment-naive
Top